[
  {
    "id": "easy-003",
    "level": "easy",
    "messages": [
      {
        "sender": "NewsDesk",
        "name": "Market Update",
        "title": "Nuclear Energy Buzz",
        "content": "Enthusiasm for nuclear is back, with Terrestrial Energy at the center. HOND SPAC is flying under the radar as it inks a deal with Terrestrial Energy, pushing its valuation higher. Keep an eye on this stealth play.",
        "tickers": ["SPAC", "HOND", "TER", "OKLO"],
        "timestamp": "2024-02-10T09:30:00Z"
      }
    ],
    "expectedActions": [
      {
        "ticker": "HOND",
        "action": "buy",
        "shares": 500,
        "quantity": 2,
        "timing": 5000
      }
    ]
  },
  {
    "id": "easy-004",
    "level": "easy",
    "messages": [
      {
        "sender": "InsiderInfo",
        "name": "CEO Moves",
        "title": "Inflection Point in AIRS",
        "content": "Insider buying from AIRS CEO signals confidence. Strong consumer demand for skin tightening services and potential tailwind from GLP-1 trends reinforce AIRS positioning.",
        "tickers": ["AIRS", "STIM", "TMS"],
        "timestamp": "2024-02-11T13:00:00Z"
      }
    ],
    "expectedActions": [
      {
        "ticker": "AIRS",
        "action": "buy",
        "shares": 500,
        "quantity": 2,
        "timing": 5000
      }
    ]
  },
  {
    "id": "easy-005",
    "level": "easy",
    "messages": [
      {
        "sender": "TradeRadar",
        "name": "Basket Update",
        "title": "CITRINDEX UPDATE",
        "content": "Adding WRBY long equal weight to the Phase 2 AI basket. Their partnership with Google has some very interesting potential.",
        "tickers": ["WRBY"],
        "timestamp": "2024-02-12T08:45:00Z"
      }
    ],
    "expectedActions": [
      {
        "ticker": "WRBY",
        "action": "buy",
        "shares": 500,
        "quantity": 2,
        "timing": 6000
      }
    ]
  },
  {
    "id": "easy-002",
    "level": "easy",
    "messages": [
      {
        "sender": "MarketBuzz",
        "name": "Trend Alert",
        "title": "Healthcare Surge",
        "content": "Renewed interest in biotech is lifting PHAR shares. The company just announced a major licensing deal with a global pharma giant. Expect positive momentum.",
        "tickers": ["PHAR", "MRK", "PFE"],
        "timestamp": "2024-02-12T10:00:00Z"
      }
    ],
    "expectedActions": [
      {
        "ticker": "PHAR",
        "action": "buy",
        "shares": 500,
        "quantity": 2,
        "timing": 4500
      }
    ]
  },
  {
    "id": "easy-001",
    "level": "easy",
    "messages": [
      {
        "sender": "InvestorNote",
        "name": "Recommendation",
        "title": "Tech Weakness",
        "content": "After a weak quarter, the recommendation is to trim positions in ZYGO to reduce exposure. The stock has underperformed expectations significantly.",
        "tickers": ["ZYGO", "INTC"],
        "timestamp": "2024-02-12T11:30:00Z"
      }
    ],
    "expectedActions": [
      {
        "ticker": "ZYGO",
        "action": "sell",
        "shares": 1000,
        "quantity": 1,
        "timing": 7000
      }
    ]
  },
  {
    "id": "medium-001",
    "level": "medium",
    "messages": [
      {
        "sender": "AnalysisTeam",
        "name": "Deep Dive",
        "title": "Renewable Boom",
        "content": "SolarEdge's recent performance and new product launch are driving optimism. However, there are concerns with FSLR's margins. We recommend increasing SEDG exposure while reducing FSLR.",
        "tickers": ["SEDG", "FSLR", "RUN"],
        "timestamp": "2024-02-13T12:00:00Z"
      }
    ],
    "expectedActions": [
      {
        "ticker": "SEDG",
        "action": "buy",
        "shares": 500,
        "quantity": 2,
        "timing": 5000
      },
      {
        "ticker": "FSLR",
        "action": "sell",
        "shares": 1000,
        "quantity": 1,
        "timing": 5000
      }
    ]
  },
  {
    "id": "medium-002",
    "level": "medium",
    "messages": [
      {
        "sender": "InvestorEdge",
        "name": "Market Strategy",
        "title": "Consumer Stocks",
        "content": "We've been tracking SKX and CROX. Strong consumer demand is favoring SKX, while CROX seems to be losing ground. Consider buying SKX and reducing CROX exposure.",
        "tickers": ["SKX", "CROX"],
        "timestamp": "2024-02-13T14:30:00Z"
      }
    ],
    "expectedActions": [
      {
        "ticker": "SKX",
        "action": "buy",
        "shares": 500,
        "quantity": 2,
        "timing": 6000
      },
      {
        "ticker": "CROX",
        "action": "sell",
        "shares": 1000,
        "quantity": 1,
        "timing": 6000
      }
    ]
  },
  {
    "id": "medium-003",
    "level": "medium",
    "messages": [
      {
        "sender": "QuickPulse",
        "name": "Trade Idea",
        "title": "EV Update",
        "content": "Tesla's performance continues to attract investors. However, Rivian's recent earnings miss and guidance have disappointed. Consider adding TSLA and trimming RIVN.",
        "tickers": ["TSLA", "RIVN", "LCID"],
        "timestamp": "2024-02-13T15:45:00Z"
      }
    ],
    "expectedActions": [
      {
        "ticker": "TSLA",
        "action": "buy",
        "shares": 500,
        "quantity": 2,
        "timing": 4000
      },
      {
        "ticker": "RIVN",
        "action": "sell",
        "shares": 1000,
        "quantity": 1,
        "timing": 4000
      }
    ]
  },
  {
    "id": "hard-001",
    "level": "hard",
    "messages": [
      {
        "sender": "HFT_Bot",
        "name": "Speed Test",
        "title": "Biotech Rapid Moves",
        "content": "Execute fast: Buy 5x MRNA, Sell 3x BNTX. Ignore others. MRNA is showing breakout momentum, while BNTX faces headwinds from delayed approvals.",
        "tickers": ["MRNA", "BNTX", "PFE", "REGN"],
        "timestamp": "2024-02-14T09:00:00Z"
      }
    ],
    "expectedActions": [
      {
        "ticker": "MRNA",
        "action": "buy",
        "shares": 500,
        "quantity": 5,
        "timing": 3000
      },
      {
        "ticker": "BNTX",
        "action": "sell",
        "shares": 1000,
        "quantity": 3,
        "timing": 3000
      }
    ]
  },
  {
    "id": "hard-002",
    "level": "hard",
    "messages": [
      {
        "sender": "FlashTrade",
        "name": "Quick Alert",
        "title": "Energy Sector Rapid Fire",
        "content": "Quick execution: Buy 5x XOM, Sell 3x CVX. Ignore the noise from other names. Crude prices are surging, boosting XOMâ€™s outlook, while CVX faces regulatory headwinds.",
        "tickers": ["XOM", "CVX", "BP"],
        "timestamp": "2024-02-14T11:20:00Z"
      }
    ],
    "expectedActions": [
      {
        "ticker": "XOM",
        "action": "buy",
        "shares": 500,
        "quantity": 5,
        "timing": 2500
      },
      {
        "ticker": "CVX",
        "action": "sell",
        "shares": 1000,
        "quantity": 3,
        "timing": 2500
      }
    ]
  }
]
